Switching after bariatric surgery Patients with a history of bariatric surgery face unique considerations when switching between GLP-1 medications
Realistic expectations and open communication with your healthcare providers are key to successful treatment outcomes
PRODUCT INFORMATION Packaging: 5 x 10 mL vials in one package Composition: Lecithin, riboflavin, bromelain Method of Administration: Mesotherapy fat lipolysis, Direct Injection Injection depth: Subcutaneous fatty layer Needle size : 30G Usage per point: 1 mL with a point interval of 1 cm (face), 1.5-2 mL with a point interval of 1.5-2 cm Maximum dosage: 50-100 mL per treatment session, depending on the treated area Precautions Avoid injecting the area around the eyes
In conclusion, this study provides robust quantitative evidence that weight regain is not a treatment failure but a predictable biological response and must be anticipated and addressed in clinical practice
Vielen Dank fr die Antwort
10.1016/j.phrs.2016.01.001 2 ByunS
